85
Participants
Start Date
December 31, 2009
Primary Completion Date
September 30, 2014
Study Completion Date
October 31, 2016
GRASPA
one injection of GRASPA 150 IU/kg at each cycle of chemotherapy
L-asparaginase
3 to 4 Injections of Native E.coli asparaginase 10000IU/m² (every 3 days) at each cycle of chemotherapy
Hopital Des Enfants Reine Fabiola, Brussels
Chr de La Citadelle, Liège
Chu D'Angers, Angers
Hopital Saint Jacques, Besançon
Hopital Pellegrin Enfants, Bordeaux
Chu Estaing, Clermont-Ferrand
Hopital Henri Mondor, Créteil
Chu Grenoble, Grenoble
Chru Lille - Hop Jeanne de Flandres, Lille
Institut Hematologie Oncologie Pediatrique, Lyon
Institut Paoli Calmettes, Marseille
Hopital Mere Enfant, Nantes
Hotel Dieu, Nantes
Hopital de L'Archet 2, Nice
Hopital Armand Trousseau, Paris
Hopital Robert Debre, Paris
Hopital Saint Louis, Paris
Hopital Haut-Leveque, Pessac
Hopital Lyon Sud, Pierre-Bénite
Chru Hopital Sud, Rennes
Centre Henri Becquerel, Rouen
Chu Hopital Nord, Saint-Etienne
Institut Cancerologie de La Loire, Saint-Priest-en-Jarez
Hopital de Hautepierre, Strasbourg
Chu de Toulouse Enfants, Toulouse
Hotel Dieu, Valenciennes
Hopital Brabois Enfants, Vandœuvre-lès-Nancy
Hopital de Brabois, Vandœuvre-lès-Nancy
Lead Sponsor
ERYtech Pharma
INDUSTRY